SLC1A4 Promotes Malignant Transformation of Hepatocellular Carcinoma by Activating the AKT Signaling
Due to the difficulty in early diagnosis and the lack of treatment for advanced disease, the mortality rate of hepatocellular carcinoma (HCC) is high, and the 5-year overall survival rate is low at present. SLC1A4 is a neutral amino acid transporter, but its regulatory role and mechanism in HCC are...
Saved in:
Main Authors: | Jiaoyun Zheng, Jian Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/ancp/1115184 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lnc-EST885 promotes hepatocellular carcinoma metastasis through PI3K / AKT pathway by interaction with TRAF4
by: Shaoliang Zhu, et al.
Published: (2025-02-01) -
circ_0001588 Induces the Malignant Progression of Hepatocellular Carcinoma by Modulating miR-874/CDK4 Signaling
by: Xiaoyun Bin, et al.
Published: (2021-01-01) -
HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib
by: Yingai Zhang, et al.
Published: (2025-01-01) -
FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway
by: Wen Meng, et al.
Published: (2020-01-01) -
GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling
by: Fan Zhang, et al.
Published: (2021-01-01)